Zobrazeno 1 - 10
of 240
pro vyhledávání: '"Theo M, de Reijke"'
Autor:
Andrea Cocci, Marta Pezzoli, Fernando Bianco, Franco Blefari, Pierluigi Bove, Francois Cornud, Gaetano De Rienzo, Paolo Destefanis, Danilo Di Trapani, Alessandro Giacobbe, Luca Giovanessi, Antonino Laganà, Giovanni Lughezzani, Guglielmo Manenti, Gianluca Muto, Gianluigi Patelli, Novello Pinzi, Stefano Regusci, Giorgio I. Russo, Juan I.M. Salamanca, Matteo Salvi, Luigi Silvestri, Fabrizio Verweij, Eric Walser, Riccardo G. Bertolo, Valerio Iacovelli, Alessandro Bertaccini, Debora Marchiori, Hugo Davila, Pasquale Ditonno, Paolo Gontero, Gennaro Iapicca, Theo M De Reijke, Vito Ricapito, Pierluca Pellegrini, Andrea Minervini, Sergio Serni, Francesco Sessa
Publikováno v:
Asian Journal of Urology, Vol 11, Iss 2, Pp 271-279 (2024)
Objective: To evaluate transperineal laser ablation (TPLA) with Echolaser® (Echolaser® TPLA, Elesta S.p.A., Calenzano, Italy) as a treatment for benign prostatic hyperplasia (BPH) and prostate cancer (PCa) using the Delphi consensus method. Methods
Externí odkaz:
https://doaj.org/article/42242771b7b7412db5d8115ef167a730
Autor:
Luigi A.M.J.G. van Riel, Rob A.A. van Kollenburg, Jan Erik Freund, Mitra Almasian, Auke Jager, Marc R.W. Engelbrecht, Ruth S. Smit, Elise Bekers, Jakko A. Nieuwenhuijzen, Pim J. van Leeuwen, Henk van der Poel, Theo M. de Reijke, Harrie P. Beerlage, Jorg R. Oddens, Daniel M. de Bruin
Publikováno v:
European Urology Open Science, Vol 54, Iss , Pp 72-79 (2023)
Background: Transperineal focal laser ablation (TPLA) treatment for prostate cancer (PCa) is an experimental focal ablative therapy modality with low morbidity. However, a dosimetry model for TPLA is lacking. Objective: To determine (1) the three-dim
Externí odkaz:
https://doaj.org/article/6475b8543ad346ccace2f880e03e2d21
Autor:
Wei Wang, Tao Zhang, Jan Nouta, Peter A. van Veelen, Noortje de Haan, Theo M. de Reijke, Manfred Wuhrer, Guinevere S.M. Lageveen-Kammeijer
Publikováno v:
Engineering, Vol 26, Iss , Pp 119-131 (2023)
Ketodeoxynononic acid (Kdn) is a rather uncommon class of sialic acid in mammals. However, associations have been found between elevated concentrations of free or conjugated Kdn in relation to human cancer progression. Hitherto, there has been a lack
Externí odkaz:
https://doaj.org/article/a218f8e8bafb472a93b2565b68e59d0e
Autor:
Ben-Max de Ruiter, Maaike W. van de Kamp, Jonah P.Z. van Steenbergen, Martine Franckena, Joost L. Boormans, Jeantine M. de Feijter, Adriaan D. Bins, Maarten C.C.M. Hulshof, Theo M. de Reijke, Eva Schaake, Jorg R. Oddens
Publikováno v:
European Urology Open Science, Vol 39, Iss , Pp 7-13 (2022)
Background: Concurrent chemoradiotherapy (CRT) as a definitive treatment option for patients with nonmetastatic muscle-invasive bladder carcinoma (MIBC) is increasingly being applied in clinical practice. Objective: To assess the oncological and toxi
Externí odkaz:
https://doaj.org/article/e0a549a6bfef4220b4eb6863be5da434
Autor:
Luigi A.M.J.G. van Riel, Rob A.A. van Kollenburg, André N. Vis, Pim J. van Leeuwen, Theo M. de Reijke, Daniel M. de Bruin, Jorg R. Oddens
Publikováno v:
European Urology Open Science, Vol 39, Iss , Pp 48-54 (2022)
Background: Soractelite™ transperineal focal laser ablation (TPLA) for the treatment of localized prostate cancer (PCa) using the Echolaser® system is a novel minimally invasive technique that has the potential to induce tissue ablation, while red
Externí odkaz:
https://doaj.org/article/c10493d5ff254f129f78a7a6431389a0
Autor:
Luigi A.M.J.G. van Riel MD, Abel Swaan MSc, PhD, Christophe K. Mannaerts MD, PhD, Rob A.A. van Kollenburg MD, C. Dilara Savci Heijink MD, PhD, Theo M. de Reijke MD, PhD, FEBU, Daniel M. de Bruin MSc, PhD, Jan Erik Freund MD, PhD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 21 (2022)
Purpose: To assess the safety and technical feasibility of in-vivo needle-based forward-looking confocal laser endomicroscopy in prostate tissue. Methods: For this feasibility study, 2 patients with a suspicion of prostate cancer underwent transperin
Externí odkaz:
https://doaj.org/article/425217deedfd461ba655b878c427263c
Autor:
Auke Jager, Luigi A.M.J.G. van Riel, Arnoud. W. Postema, Theo M. de Reijke, Tim M. van der Sluis, Jorg R. Oddens
Publikováno v:
Therapeutic Advances in Urology, Vol 14 (2022)
Purpose: The introduction of magnetic resonance imaging (MRI)-targeted biopsy (TBx) besides systematic prostate biopsies has resulted in a discussion on what the optimal prostate biopsy strategy is. The ideal template has high sensitivity for clinica
Externí odkaz:
https://doaj.org/article/d82cb1ae3c5e4942962e8b88545efde5
Autor:
Luigi A.M.J.G. van Riel, Auke Jager, Dennie Meijer, Arnoud W. Postema, Ruth S. Smit, André N. Vis, Theo M. de Reijke, Harrie P. Beerlage, Jorg R. Oddens
Publikováno v:
Therapeutic Advances in Urology, Vol 14 (2022)
Purpose: A pre-biopsy decision aid is needed to counsel men with a clinical suspicion for clinically significant prostate cancer (csPCa), despite normal prostate magnetic resonance imaging (MRI). Methods: A risk calculator (RC) for csPCa (Internation
Externí odkaz:
https://doaj.org/article/1bc1b35445a74501a136c6dc4cf71b0a
Autor:
Noor van Ginkel, Erik J. van Gennep, Liselot Oosterbaan, Joyce Greidanus, Thierry N. Boellaard, Maurits Wondergem, André N. Vis, Theo M. de Reijke, Bas W.G. van Rhijn, Laura S. Mertens
Publikováno v:
Clinical genitourinary cancer. Elsevier
Introduction and Objectives: 18F-fluorodeoxyglucose positron-emission tomography-computed tomography (FDG-PET/CT) is increasingly used in the preoperative staging of patients with muscle-invasive bladder cancer. The clinical added value of FDG-PET/CT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a071379e6b14839cad93b6dbd77ea08
https://doi.org/10.1016/j.clgc.2023.02.004
https://doi.org/10.1016/j.clgc.2023.02.004
Autor:
Remco J. Molenaar, Jons W. van Hattum, Iris S. Brummelhuis, Jorg R. Oddens, C. Dilara Savci-Heijink, Egbert R. Boevé, Saskia A. van der Meer, J. Fred Witjes, Michael N. Pollak, Theo M. de Reijke, Johanna W. Wilmink
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background Non-muscle-invasive bladder cancer (NMIBC) is the most common neoplasm of the urinary tract and requires life-long invasive surveillance to detect disease recurrence. Currently, there are no effective oral therapies that delay dis
Externí odkaz:
https://doaj.org/article/1ec18dea93844ba5ad23b9d0b91d5413